Cellular glutathione content in the organ of Corti and its role during ototoxicity
Simon G, DiNardo CD, Takahashi K, Cascone T, Powers C, Stevens R, Allen J, Antonoff MB, Gomez D, Keane P, Suarez Saiz F, Nguyen Q, Roarty E, Pierce S, Zhang J, Hardeman Barnhill E, Lakhani K, Shaw K, Smith B, Swisher SG , High R, Futreal PA, Heymach J, Chin L
Foundayo (Orforglipron) As the newest GLP-1 medication approved in April 2026, Foundayo offers the maximum flexibility with its once-daily pill format
"FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice." Aging